Level 2 · Controlled trialRandomised controlled trial

Omega-3 fatty acids effectively mitigate high-sensitivity C-reactive protein (hs-CRP) biomarker of inflammation in acute myocardial infarction patients: a randomized, double-blind, placebo-controlled clinical trial

Ahmadi M, Askari VR, Shahri B, Mousavi Noghab SM, Jarahi L, Baradaran Rahimi V

Naunyn-Schmiedeberg's archives of pharmacology · 29 July 2024

AUTHORS’ ABSTRACT

The abstract of this article is not reproduced here: its licence does not allow it. It can be read freely on the journal’s website or on Europe PMC.

Scientific information content; it does not replace the advice of a healthcare professional. The presence of a study in this library does not constitute a claim about our products.

← All studies